Health and Medicine
-
November 15, 2021
Who’s who in the respiratory landscape
A metatranscriptomics method developed by Vanderbilt researchers simultaneously characterizes viruses, microbiome and host response in nasal swabs, opening opportunities to explore molecular interactions directly in clinical samples. -
November 11, 2021
CRISPR screen identifies new anti-inflammatory drug target
A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics. -
November 11, 2021
The power of white matter
Using a novel analysis of fMRI data, Vanderbilt researchers discovered intriguing patterns of signals in the brain’s white matter, the “conduit” for relaying signals between different brain regions. -
November 11, 2021
New way to bEET insulin resistance
Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered. -
November 11, 2021
International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes
-
November 11, 2021
Translational Research Forum honors scientific excellence
Vanderbilt University Medical Center’s strength in translational research, which helps “translate” scientific discovery into medical practice, was celebrated recently during the Vanderbilt Translational Research Forum -
November 4, 2021
Harrison Society researcher discovers key regulator of kidney cell structure
New research from Vanderbilt could aid efforts to promote kidney regeneration after injury or to develop engineered organs.